王 健
环丙沙星与氨茶碱联合治疗慢性阻塞性肺气肿的临床分析
王 健
【摘要】目的 对慢性阻塞性肺气肿应用环丙沙星与氨茶碱联合治疗的临床疗效进行分析研究。方法 选取于2013年11月~2016年1月在我院接受治疗的慢性阻塞性肺气肿患者119例,并随机分为对照组(58例)和实验组(61例),对分别应用单纯氨茶碱和环丙沙星与氨茶碱联合治疗的效果进行对照研究。结果 实验组患者的显效率、治疗总有效率均高于对照组[62.30%、91.80% vs. 34.48%、72.41%],pH、PaO2高于对照组,PaCO2低于对照组,不良反应发生率低于对照组[9.84% vs. 29.31%],差异有统计学意义(P<0.05)。结论 慢性阻塞性肺气肿应用环丙沙星与氨茶碱联合治疗的临床疗效十分满意。
【关键词】环丙沙星;氨茶碱;慢性阻塞性肺气肿
Objective Ciprofloxacin combined with aminophylline effect in treatment of chronic obstructive emphysema is to be studied. Methods Chose 119 patients with chronic obstructive emphysema who were treated in hospital from November 2013 to January 2016 and separated them into control group (58 patients)and study group(61 patients),and then compared only aminophylline treatment effect to ciprofloxacin combined with aminophylline treatment effect between two groups. Results Patients’ explicit efficiency and treatment efficacy were much higher than counterparts in control group [62.30%、91.80% vs. 34.48%、72.41%],and patients’ diameters of pH and PaO2were to be tested higher,but PaCO2was much lower in study group compared to those in control group,besides,side-effect incidence in study group was much lower than that in control group [9.84% vs. 29.31%],thus,there was a differential between two groups and such a differential had statistic value(P<0.05). Conclusion Ciprofloxacin combined with aminophylline is quite clinically effective in treatment of chronic obstructive emphysema.
【Key words】 Ciprofloxacin,Aminophylline,Chronic obstructive emphysema
慢性阻塞性肺气肿是临床上一种由支气管哮喘、慢性支气管炎、支气管扩张等疾病所导致的呼吸系统的病理改变,随着吸烟以及大气污染等因素的影响,该病的发病率更是呈现出居高不下的发展趋势[1]。本院将环丙沙星与氨茶碱联合治疗应用于2013年11月~2016年1月收治的慢性阻塞性肺气肿患者中,效果理想,现报道如下。
1.1 一般资料
选取于2013年11月~2016年1月在我院接受治疗的慢性阻塞性肺气肿患者119例,其中男性患者、女性患者的人数分别是66例和53例;年龄42~80岁,平均年龄(55.44±2.74)岁;病程1.8~18.5年,平均病程(8.15±1.08)年;其中36例患者为慢性支气管炎,40例患者为哮喘病,43例患者存在3年以上吸烟史。采用多中心、随机、平行、对照设计的研究方法将上述患者按密封信封法随机分为对照组(58例)和实验组(61例),上述基本资料经检验对照组和实验组患者差异无统计学意义,P>0.05。……